Alexander Romanishin

Dr. Alexander Romanishin


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2024 in Virology
Verified
Journal Article
Closed access
ARAlexander Romanishin
Alexander Romanishin
AVA. Vasilev
A. Vasilev
EKE. Khasanshin
E. Khasanshin
AEA. Evtekhov
A. Evtekhov
EPE. Pusynin
E. Pusynin
ESE. Semina
E. Semina

13 December 2021 in Cells
Verified
Journal Article
Open access
PDF file
JRJulian Markovich Rozenberg
Julian Markovich Rozenberg
SZSvetlana Zvereva
Svetlana Zvereva
ADAlexandra Dalina
Alexandra Dalina
IBIgor Blatov
Igor Blatov
IZIlya Zubarev
Ilya Zubarev
Nick BarlevNick Barlev
Nick Barlev
Understanding the mechanisms that regulate cancer progression is pivotal for the development of new therapies. Although p53 is mutated in half of human cancers, its family member p73 is not. At the same time, isoforms of p73 are often overexpressed in cancers and p73 can overtake many p53 functions to kill abnormal cells. According to the latest studies, while p73 represses epithelial–mesenchymal transition and metastasis, it can also promote tumour growth by modulating crosstalk between cancer and immune cells in the tumor microenvironment, M2 macrophage polarisation, Th2 T-cell differentiation, and angiogenesis. Thus, p73 likely plays a dual role as a tumor suppressor by regulating apoptosis in response to genotoxic stress or as an oncoprotein by promoting the immunosuppressive environment and immune cell differentiation.

25 November 2022 in Marine Drugs
Verified
Journal Article
Open access
PDF file
Vladlena A TiastoVladlena A Tiasto
Vladlena A Tiasto
NGNikolay V Goncharov
Nikolay V Goncharov
ARAlexander Romanishin
Alexander Romanishin
Maxim E. ZhidkovMaxim E. Zhidkov
Maxim E. Zhidkov
YKYuri Khotimchenko
Yuri Khotimchenko
The carrageenans isolated from red algae demonstrated a variety of activities from antiviral and immunomodulatory to antitumor. The diverse structure and sulfation profile of carrageenans provide a great landscape for drug development. In this study, we isolated, purified and structurally characterized κo- and λo- oligosaccharides from the marine algae Chondrus armatus. We further examined the tumor suppressive activity of both carrageenans in gastrointestinal cancer models. Thus, using MTT assay, we could demonstrate a pronounced antiproliferative effect of the carrageenans in KYSE-30 and FLO-1 as well as HCT-116 and RKO cell lines with IC50 184~405 μg/mL, while both compounds were less active in non-cancer epithelial cells RPE-1. This effect was stipulated by the inhibition of cell cycle progression in the cancer cells. Specifically, flow cytometry revealed an S phase delay in FLO-1 and HCT-116 cells under κo-carrageenan treatment, while KYSE-30 demonstrated a pronounced G2/M cell cycle delay. In line with this, western blotting revealed a reduction of cell cycle markers CDK2 and E2F2. Interestingly, κo-carrageenan inhibited cell cycle progression of RKO cells in G1 phase. Finally, isolated κo- and λo- carrageenans induced apoptosis on adenocarcinomas, specifically with high apoptosis induction in RKO cells. Overall, our data underline the potential of κo- and λo- carrageenans for colon and esophageal carcinoma drug development.

12 September 2025 in Chemistry of plant raw material
Verified
Journal Article
Open access
PDF file
VLViktoriia Larina
Viktoriia Larina
ARAlexander Romanishin
Alexander Romanishin
PKPolina Konstantinovna Kleshchina
Polina Konstantinovna Kleshchina
DKDaniil Dmitrievich Krotov
Daniil Dmitrievich Krotov
CEChupakhin Evgeny
Chupakhin Evgeny
Glycyrrhiza glabra L. (Fabaceae family) is rich in various biologically active components, however, the antitumor activity of G. glabra extracts and its components against glioblastoma has been poorly studied to date. Glycycoumarin, glycyrrhetinic acid, glycyrrhizin, licochalcones A and E, etc. are usually described as anticancer components of G. glabra. The aim of this work was to screen the antitumor activity of heteropolar extracts of G. glabra root against rat glioblastoma C6 cells; to determine the antitumor component of the most active extract. Eight G. glabra extracts were obtained using heteropolar extractants: hexane, ethyl acetate, acetone, methanol, ethanol, 70% acetone, 70% methanol, 70% ethanol, and water. The highest antitumor activity against C6 cells was demonstrated by the extract obtained with 70% ethanol (IC50 49.16 μg/ml), while it did not have high cytotoxicity against normal cells at low concentrations. This extract was distinguished by a high content of catechin and daidzein. The fraction obtained with a chloroform – methanol (8 : 2) solution showed the highest activity against rat glioblastoma C6 cells. Daidzein was isolated from this fraction in individual form. An MTT test study showed that daidzein is active against C6 tumor cells (IC50 68.29 μg/ml), but also has cytotoxicity against normal cells (IC50 68.93 μg/ml).